KEY POINTS
- This clinical image-based report describes a 63-year-old man undergoing definitive chemoradiotherapy for HPV-positive oropharyngeal squamous cell carcinoma who developed significant nutritional deterioration during treatment. After 20 of 33 prescribed fractions, approximately four weeks into RT, he had lost 11.1% of his body weight, primarily because of dysgeusia, reduced appetite and inadequate oral intake.
- Daily cone-beam CT demonstrated substantial interval soft-tissue loss and changes in external anatomy, producing a visible mismatch between the original treatment contours and the patient's current anatomy. The serial CT images illustrate displacement of the original high- and intermediate-risk target relationships following weight loss, highlighting the need to assess treatment geometry rather than relying exclusively on body-weight measurements.
- A small-bore Dobhoff nasogastric tube was inserted in the outpatient clinic to provide nutritional support. Direct nasolaryngoscopy guided passage of the tube into the esophagus, while a subsequent chest radiograph confirmed its location within the stomach; three-dimensional CT reconstruction also demonstrated the tube's trajectory through the irradiated anatomy.
- Repeat CT simulation was completed on the same day as nasogastric tube insertion, allowing target recontouring and adaptive replanning for the altered head and neck anatomy. The adapted treatment began the following day, demonstrating that nutritional intervention and reassessment of treatment geometry can be coordinated without a prolonged interruption.
- The report illustrates the complementary roles of daily CBCT, direct nasolaryngoscopy, chest radiography and repeat planning CT. CBCT identified clinically important anatomical changes, endoscopy and chest radiography supported safe tube placement, and repeat simulation supplied updated imaging for treatment planning; however, the article does not provide numerical differences in target coverage, OAR doses or accumulated dose.
- The authors cite previous literature supporting nasogastric feeding as an alternative to gastrostomy in selected head and neck cancer patients, including reports of comparable nutritional outcomes and potentially greater preservation of swallowing function. These findings come from previously published studies rather than the presented case, which did not report longitudinal nutritional recovery, swallowing outcomes, comparative toxicity or long-term disease control.
CLINICAL TAKEAWAY
Significant weight loss during head and neck chemoradiotherapy may simultaneously require nutritional intervention and adaptive reassessment of target anatomy. This case demonstrates that nasogastric feeding-tube placement and repeat simulation can be integrated into the existing RT workflow, but does not establish specific weight-loss thresholds for replanning or comparative advantages over gastrostomy feeding.